1. Al Ghadeer, Hussain A, Alghazal, Fouad A, Alessa, Marwah A, Almumtin, Khulud A, Abu Sinah, Ahmed K. 2023. DIS3L2 Gene Mutation Causes the Perlman Syndrome of Overgrowth and Wilms Tumor Susceptibility. In Cureus, 15, e49777. doi:10.7759/cureus.49777. https://pubmed.ncbi.nlm.nih.gov/38161545/
2. Luan, Siyu, Luo, Junyun, Liu, Hui, Li, Zhaoyong. 2019. Regulation of RNA decay and cellular function by 3'-5' exoribonuclease DIS3L2. In RNA biology, 16, 160-165. doi:10.1080/15476286.2018.1564466. https://pubmed.ncbi.nlm.nih.gov/30638126/
3. García-Moreno, Juan F, Lacerda, Rafaela, da Costa, Paulo J, Matos, Paulo, Romão, Luísa. 2023. DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway. In Cellular and molecular life sciences : CMLS, 80, 185. doi:10.1007/s00018-023-04833-5. https://pubmed.ncbi.nlm.nih.gov/37340282/
4. Li, Nana, Yu, Junjie, Feng, Yan-Qin, Xu, Yu, Wang, Zhengpin. 2024. Conditional ablation of DIS3L2 ribonuclease in pre-meiotic germ cells causes defective spermatogenesis and infertility in male mice. In Theranostics, 14, 5621-5642. doi:10.7150/thno.98620. https://pubmed.ncbi.nlm.nih.gov/39310107/
5. Xing, Songge, Li, Zhaoyong, Ma, Wenhao, Jia, Wei-Dong, Zhang, Huafeng. 2019. DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing. In Cancer research, 79, 4923-4936. doi:10.1158/0008-5472.CAN-19-0376. https://pubmed.ncbi.nlm.nih.gov/31331910/